AJO LP’s CONMED CNMD Stock Holding History

AJO LP’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21,351	Closed	-$1.37M	–	673
2018 Q4	$1.37M	Buy	+21,351	New	+$1.46M	0.01%	485

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AJO LP's CNMD Position: Q1 2019 in Review

AJO LP sold out of CONMED (CNMD) in Q1 2019, closing a stake of 21,351 shares — an estimated $1.37M sold.

AJO LP first reported a position in CNMD in Q4 2018 and held it in 1 quarter. The position peaked at $1.37M in Q4 2018. 226 funds tracked by Wall St. Rank hold CNMD as of Q1 2019.

AJO LP reported no remaining CONMED position as of Q1 2019 after selling out during the quarter.
AJO LP sold 21,351 CONMED shares in Q1 2019, an estimated $1.37M.
AJO LP first reported a position in CONMED in Q4 2018 and held it in 1 quarter.
AJO LP's CONMED position peaked at $1.37M in Q4 2018.
226 funds tracked by Wall St. Rank held CONMED as of Q1 2019.

Based on AJO LP's 13F filing for Q1 2019, filed 10 May 2019.